概括
脑下垂体病变增加了小鼠的胰岛素耐药性,需要双倍的胰岛素剂量来诱导. 即使高剂量的胰岛素也未能在大多数受损小鼠中引起发作,尽管血糖显著降低.
科学领域:
- 神经内分泌学神经内分泌学
- 代谢研究的研究.
背景情况:
- 下丘脑调节葡萄糖平衡和胰岛素敏感性.
- 众所周知,腹部中枢下丘脑 (VMH) 病变会导致肥胖和代谢障碍.
研究的目的:
- 为了研究VMH病变对胰岛素诱导的的影响.
- 评估VMH损伤后胰岛素敏感性和葡萄糖调节的变化.
主要方法:
- 在小鼠身上,VMH病变的治疗方法是使用黄金硫糖.
- 进行胰岛素耐受性测试,测量所需的剂量.
- 在胰岛素注射后监测血糖水平.
主要成果:
- 与对照组相比,受伤小鼠需要加倍胰岛素剂量,以达到50%的发病率.
- 即使是最大的胰岛素剂量 (50mU/g) 也没有在超过60%的受损小鼠中引起.
- 在受损小鼠中,血糖水平降至24mg/dL,但没有引起广泛的发作.
结论:
- VMH病变显著损害了胰岛素诱发的能力.
- 这表明VMH损伤后的葡萄糖调节和/或胰岛素敏感性发生了重大变化.
- VMH在调解胰岛素的全身作用,包括发作诱导方面发挥着至关重要的作用.
相关概念视频
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


